Metraipolis › archive › dc_cb6a5356dd52

ATAD2 drives melanoma growth and progression and inhibits ferroptosis — Europe PMC PMID:41331524

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41331524
DOI
10.1038/s44319-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-08T00:32:00.003Z
SHA-256 of the archived text
5d305bac3f18dc31b186c3cf07cbfab27175246f174225d74f161a33760b85ae
Stable URL of this page
https://metraipolis.com/documento/dc_cb6a5356dd52

How to cite

ATAD2 drives melanoma growth and progression and inhibits ferroptosis — Europe PMC PMID:41331524 — Europe PMC (en), https://europepmc.org/article/MED/41331524 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb6a5356dd52 (Metraipolis archive dc_cb6a5356dd52, sha256 5d305bac3f18dc31b186c3cf07cbfab27175246f174225d74f161a33760b85ae)
BibTeX
@misc{dccb6a5356dd52,
  title = {ATAD2 drives melanoma growth and progression and inhibits ferroptosis — Europe PMC PMID:41331524},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41331524},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb6a5356dd52; sha256 5d305bac3f18dc31b186c3cf07cbfab27175246f174225d74f161a33760b85ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41331524. Agents can read the archived copy with the MCP tool read_document.